DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency

By
Noshin Noorjahan
-
0
46
The authors developed CRISPR-based methods to directly correct DNMT3AR882 mutations in leukemic cells obtained from patients.
[Cancer Discovery]
Abstract